AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 49 filers reported holding AC IMMUNE SA in Q4 2020. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,420 | -57.6% | 1,200 | -56.1% | 0.00% | – |
| Q2 2023 | $8,073 | +34.6% | 2,732 | 0.0% | 0.00% | – |
| Q1 2023 | $6,000 | +99900.0% | 2,732 | 0.0% | 0.00% | – |
| Q4 2022 | $6 | -100.0% | 2,732 | -48.2% | 0.00% | – |
| Q3 2022 | $17,000 | +30.8% | 5,271 | +50.1% | 0.00% | – |
| Q2 2022 | $13,000 | -65.8% | 3,512 | -62.8% | 0.00% | – |
| Q1 2022 | $38,000 | +8.6% | 9,430 | +34.1% | 0.00% | – |
| Q4 2021 | $35,000 | -67.9% | 7,032 | -56.4% | 0.00% | – |
| Q3 2021 | $109,000 | +303.7% | 16,131 | +368.8% | 0.00% | – |
| Q2 2021 | $27,000 | – | 3,441 | +10327.3% | 0.00% | – |
| Q1 2021 | $0 | – | 33 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 33 | -99.3% | 0.00% | – |
| Q4 2019 | $43,000 | -56.6% | 5,059 | -72.1% | 0.00% | – |
| Q2 2019 | $99,000 | +30.3% | 18,162 | +20.7% | 0.00% | – |
| Q1 2019 | $76,000 | -46.5% | 15,049 | -15.5% | 0.00% | – |
| Q3 2018 | $142,000 | +1083.3% | 17,803 | +1467.2% | 0.00% | – |
| Q1 2017 | $12,000 | – | 1,136 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 7,428,379 | $29,714,000 | 1.19% |
| ACUTA CAPITAL PARTNERS, LLC | 100,000 | $400,000 | 0.19% |
| Artal Group S.A. | 1,000,000 | $4,000,000 | 0.17% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,062,462 | $4,250,000 | 0.13% |
| Kingsbury Capital Investment Advisors LLC | 18,975 | $76,000 | 0.08% |
| EcoR1 Capital, LLC | 485,005 | $1,940,000 | 0.06% |
| Virtus ETF Advisers LLC | 31,014 | $124,000 | 0.06% |
| Eversept Partners, LP | 124,589 | $498,356 | 0.04% |
| COHEN LAWRENCE B | 12,850 | $51,000 | 0.03% |
| ALPINE WOODS CAPITAL INVESTORS, LLC | 50,000 | $200,000 | 0.02% |